Open company graph database — free web & API
Login

Terumo Medical Corporation

TERUMO CORPORATIONAliasテルモ株式会社Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
30,689
Related companies
4
§01

Basic information

BASIC
Head office
Tokyo, Japan
Chief executive
Hikaru Samejima
Capital
38 JPY
Employees (non-consolidated)
Employees (consolidated)
30,689 people
Start date
1972-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

4
Medical Devices and SuppliesPharmaceutical SolutionsHealth OutcomesProduct Design and Development Services
§04

Related companies

4 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Terumo Corporation
Group Parent
Terumo Medical Canada Inc.
Group Subsidiary
Thermo Group
Group
Terumo Puerto Rico, LLC
Group Subsidiary
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

78 EVENTS

Founded 1921, Headquarters TOKYO, JAPANSources

Foundation of Red Line Thermometer Corporation by a group of medical scientists led by Dr. Shibasaburo Kitasato for the purpose of manufacturing accurate clinical thermometers in JapanSources

Launch of Jintan Taionkei, the company’s first clinical thermometer, in JapanSources

Change of company name to Jintan Thermometer CorporationSources

Launch of Japan’s first disposable syringeSources

Launch of Japan’s first disposable hypodermic needleSources

Launch of Japan’s first blood bagSources

Establishment of a local affiliate in the U.S.Sources

Establishment of a local affiliate in Europe (Belgium)Sources

Founded 1972, Headquarters SOMERSET, NJSources

Launch of Japan’s first intravenous solutions in soft plastic bags, based on the technology accumulated through the development of blood bagsSources

Change of company name to Terumo CorporationSources

Launch of the hollow fiber dialyzer and entry to the field of artificial organsSources

Launch of Japan’s first parenteral nutrient solution in soft plastic bagsSources

Launch of the world’s first microporous hollow-fiber membrane oxygenatorSources

Listing of the company in the 2nd Section of the Tokyo Stock ExchangeSources

Launch of Japan’s first digital thermometer for hospitalsSources

Termination of mercury thermometer production and implementation of efforts to spread digital thermometersSources

Designation of the company for listing in the 1st Section of the Tokyo Stock ExchangeSources

Launch of the angiographic catheter system in Japan and entry to the field of vascular interventionSources

Launch of the peritoneal dialysis system in JapanSources

Establishment of the Shonan Center R&D facility in JapanSources

Launch of the blood glucose monitor in JapanSources

Foundation of Terumo Medical Products (Hangzhou) Co., Ltd. (China)Sources

Foundation of Changchun Terumo Medical Products Co., Ltd. (China)Sources

Establishment of Terumo Penpol Pvt. Ltd. (India) as a joint venture expanding the company’s business in blood transfusion productsSources

The cardiovascular division of 3M joins Terumo Group, establishing Terumo Cardiovascular Systems Corp. (U.S.)Sources

Launch of prefilled syringes in JapanSources

Start of production at Terumo (Philippines) Corp.Sources

Introduction of the closed infusion system in JapanSources

The home oxygen division of Sumitomo Bakelite Co., Ltd. (Japan) joins Terumo Group, establishing Terumo Medical Care K.K.Sources

Ikiken Co., Ltd. (Japan) joins Terumo GroupSources

Transfer of dialyzer marketing operations from Terumo to Asahi MedicalSources

Establishment of Terumo Medical Pranex, a training facility for medical professionals in JapanSources

Vascutek Ltd. (U.K.), a manufacturer of vascular grafts, joins Terumo GroupSources

Launch of the world’s first high-calorie IV solution containing multivitaminsSources

Launch of the world’s thinnest injection needle for administering insulin and other medications in JapanSources

MicroVention Inc. (U.S.), a neurovascular intervention device company, joins Terumo Group, marking Terumo’s entry to neurovascular intervention therapy with embolization coils for treating brain aneurysmsSources

Establishment of Olympus Terumo Biomaterials Corp. (Japan), a joint venture with Olympus Corp.Sources

The heart valve division of Dr. Franz Köhler Chemie GmbH (Germany) joins Terumo Group, expanding Terumo’s operations related to vascular prosthesesSources

Start of production at Terumo Vietnam Co., Ltd.Sources

Release of magnetically levitated centrifugal left ventricular assist systems in EuropeSources

Launch of drug-eluting coronary stent in EuropeSources

Clinical Supply Co., Ltd. (Japan), a manufacturer of interventional oncology devices, joins Terumo Group, enhancing Terumo’s interventional systems business in the field of radiotherapySources

Foundation of Terumo Americas Holding, Inc.Sources

Harvest Technologies Corp., a leader in the development of point-of-care cell therapy, joins Terumo GroupSources

CaridianBCT Holding Corp. (currently Terumo Blood and Cell Technologies), a global leader in the blood transfusion industry, joins Terumo GroupSources

Harvest Technologies Corp., a leader in the development of point-of-care cell therapy, joins Terumo GroupSources

Release of magnetically levitated centrifugal left ventricular assist systems in JapanSources

Foundation of Terumo (China) Holding Co., Ltd.Sources

Foundation of Terumo Yamaguchi Corp.Sources

Onset Medical Corp., a leader in innovative sheath technology, joins Terumo GroupSources

Foundation of Terumo Asia Holdings Pte. Ltd.Sources

Establishment of the Austria Branch of Terumo Deutschland GmbHSources

Terumo joins the United Nations Global CompactSources

Introduction of the IV solution bag for safe administration in JapanSources

Introduction of infusion systems that can be connected to hospital IT systems in JapanSources

Launch of the thoracic frozen elephant trunk in EuropeSources

Foundation of Wego Terumo (Weihai) Medical Products Co., Ltd. for the Peritoneal Dialysis BusinessSources

Foundation of Terumo BCT Vietnam Co., Ltd.Sources

Foundation of Terumo Russia LLCSources

Foundation of Terumo India Pvt. Ltd.Sources

Introduction of a series of vital measuring devices with communication functions in JapanSources

Foundation of Terumo Medical InnovationSources

Introduction of the autologous skeletal myoblast sheet, the world’s first approved regenerative medicine for cardiac regenerative therapy in Japan, with sales beginning in 2016Sources

Addition of the world’s first intrasaccular device to the aneurysm treatment portfolioSources

Bolton Medical, Inc. (U.S.), a manufacturer of stent grafts for aortic treatment, joins Terumo GroupSources

The vascular closure business and other assets of Abbott and St. Jude Medical join Terumo GroupSources

Approval of Japan’s first insulin patch pumpSources

Launch of the new business brand “Terumo Aortic”Sources

Essen Technology (Beijing) Co., Ltd. (China), a specialized enterprise of coronary interventional devices, joins Terumo GroupSources

Rebuilding of the Terumo Group Identity with newly established Core ValuesSources

Launch of the cell therapy fill and finish systemSources

Rebuilding of the Terumo Group Identity with newly established Core ValuesSources

Rebrand to “Blood and Cell Technologies Company” to reflect the strengthening cell therapy fieldSources

100th anniversary of the Terumo GroupSources

Launch of the new business brand “Terumo Medical Care Solutions”Sources

Foundation of Terumo South Africa (Pty) Ltd.”Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑